Ronald E. Law, Ph.D., J.D. (Chicago)
Global strategic adviser, AcaHealth Pharma & Biotech Company
B.S., Biological Sciences; University of Illinois at Chicago
M.S., Biological Sciences; University of Illinois at Chicago
Ph.D., Molecular Biology; University of California at Los Angeles
J.D., Whittier College School of Law, Magna cum laude, CA
NSRA Predoctoral Fellow in Genetics and Regulatory Mechanisms, UCLA, Molecular Biology, 1985-1987
University of California Cancer Research Coordinating Committee UCLA, Dept. of Microbiology and Immunology, 1987-1988
USPHS Postdoctoral Fellow in Neurology, USC School of Medicine, Dept. of Neurology and Norris Cancer Center, 1990-1991
Assistant Professor, University of Southern California School of Medicine, Division of Endocrinology, Diabetes, and Hypertension,1992
Assistant Professor of University of Southern California School of Medicine, Endocrinology, Diabetes, Diabetes and Hypertension. 1994
Assistant Professor of Medicine, UCLA 1997
Associate Professor of Medicine, UCLA. 2002
Director & Senior Director Medical and Scientific Product Evaluation, Takeda Pharmaceuticals of North America, 2004-2007
Vice President, Global Scientific Affairs, Strategic Product Planning Department (Takeda Corporate), 2008-2010
Vice President, Global Scientific Affairs and Intelligence, Strategic Product Planning Department (Takeda), 2010-2012
Vice President, New Frontier Science, Takeda Pharmaceuticals International, 2012-2016
Head of Medical Affairs Consultant, PharmaIN– October, 2016-March, 2017
Cosultant of Third Coast Therapeutics- April. 2017 to present
Chief Strategy Officer at Oramed Pharmaceuticals- March, 2017 to July, 2018
Cosultant of Doctor Evidence- October, 2016-March, 2017
Principal Executive Officer, BioSpecific’s Technology Corporation-July, 2018 to April 2020
Head, Medical Affairs, Alta Thera-April 2020 to presentAdvisor, Scohia– April 2020 to present